LLSCX
Price
$29.06
Change
+$0.19 (+0.66%)
Updated
Oct 17 closing price
Net Assets
734M
VSCIX
Price
$121.32
Change
-$0.03 (-0.02%)
Updated
Oct 17 closing price
Net Assets
162.36B
Interact to see
Advertisement

LLSCX vs VSCIX

Header iconLLSCX vs VSCIX Comparison
Open Charts LLSCX vs VSCIXBanner chart's image
Longleaf Partners Small-Cap
Price$29.06
Change+$0.19 (+0.66%)
VolumeN/A
Net Assets734M
Vanguard Small Cap Index I
Price$121.32
Change-$0.03 (-0.02%)
VolumeN/A
Net Assets162.36B
LLSCX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
LLSCX vs. VSCIX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLSCX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 162B vs. LLSCX (734M). VSCIX pays higher dividends than LLSCX: VSCIX (1.35) vs LLSCX (0.10). LLSCX was incepted earlier than VSCIX: LLSCX (37 years) vs VSCIX (28 years). LLSCX (1.04) is less costly to investors than VSCIX (0.04). LLSCX is a more actively managed with annual turnover of: 27.00 vs. VSCIX (13.00). LLSCX has a lower initial minimum investment than VSCIX: LLSCX (10000) vs VSCIX (5000000). VSCIX (4.95) and LLSCX (4.72) have marching annual gain over last year. VSCIX return over 5 years is better than : 55.48 vs. LLSCX (37.66).
LLSCXVSCIXLLSCX / VSCIX
Total Expense Ratio0.950.042,375%
Annual Report Gross Expense Ratio1.040.042,600%
Fund Existence37 years28 years-
Gain YTD6.2135.610111%
Front LoadN/AN/A-
Min. Initial Investment1000050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets734M162B0%
Annual Yield % from dividends0.101.358%
Returns for 1 year4.724.9595%
Returns for 3 years41.3242.0498%
Returns for 5 years37.6655.4868%
Returns for 10 years16.01130.9212%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD6.580.10
+1.54%
Tvardi Therapeutics Inc
GRRR16.950.18
+1.07%
Gorilla Technology Group
SYRE22.470.23
+1.03%
Spyre Therapeutics
DVA125.880.63
+0.50%
DaVita
LANDM24.94N/A
N/A
Gladstone Land Corp